In late-life depression (LLD), several differences between patients whose first episode is reported after age 65 (late-onset depression, LOD) and those with early-onset depression (EOD) might reflect the effects of brain ageing. To test this hypothesis, we analysed the impact of current age and age at illness onset on a number of clinical and cognitive manifestations in 438 outpatients with major depressive disorder aged >60 years, treated with venlafaxine for 12 weeks. When compared to the EOD group, patients with LOD were older (P< 0.00001) and associated with lower depression severity (P= 0.0029), lower global cognitive functioning [Mini-Mental State Examination (MMSE):P= 0.0001; Repeatable Battery for the Assessment of Neuropsychological Status: immediate memory,P= 0.0009, and delayed memory,P< 0.00001; Delis-Kaplan Executive Function System measuring executive functions: Trail-Making Test (TMT) –P= 0.0004 and Colour-Word Interference Test, Inhibition –P= 0.0063], and more dyskinesias (Abnormal Involuntary Movement Scale:P= 0.0006). After controlling for its interactions with age of onset, current age was inversely correlated with Montgomery Åsberg Depression Rating Scale scores at baseline (P< 0.00001) and week 12 (P= 0.0066), MMSE (P< 0.00001), delayed memory (P< 0.00001), and TMT (P= 0.0021). Age of onset predicted impairment in immediate (P= 0.023) and delayed memory (P= 0.0181), and dyskinesias (P= 0.0006). Although most features of LLD are related to ageing rather than to late-onset, LOD is a possible separate diagnostic entity characterised by memory dysfunction and increased liability to movement disorders.